Mizuho Reiterates Outperform Rating on Belite Bio, Inc, ADR (BLTE): "very well positioned"
Tweet Send to a Friend
Mizuho analyst Graig Suvannavejh reiterated an Outperform rating and $223.00 price target on Belite Bio, Inc, ADR (NASDAQ: BLTE)The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
